5:11 PM
 | 
Feb 29, 2012
 |  BC Extra  |  Top Story

Dainippon to acquire Boston Biomedical

Dainippon Sumitomo Pharma Co. Ltd. (Tokyo:4506; Osaka:4506) will acquire cancer stem cell company Boston Biomedical Inc. (Norwood, Mass.) for $200 million up front, plus up to $540 million...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >